Reuters logo
BRIEF-Mirna therapeutics' investigational new drug for MRX34 has been placed on full clinical hold
2016年9月29日 / 晚上9点17分 / 1 年前

BRIEF-Mirna therapeutics' investigational new drug for MRX34 has been placed on full clinical hold

Sept 29 (Reuters) - Mirna Therapeutics Inc

* Investigational new drug for MRX34, investigational Microrna Therapy for multiple cancers, has been placed on full clinical hold

* Anticipates that it will receive a formal clinical hold letter from FDA within 30 days - SEC filing Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below